Drug
Famotidine, Calcium Carbonate, Magnesium Hydroxide Chewable Tablet
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | End Stage Renal Disease | 121 | 67.0 | 71.1 | signal |
| 2 | Chronic Kidney Disease | 443 | 58.9 | 74.7 | signal |
| 3 | Product Physical Issue | 78 | 39.8 | 41.4 | signal |
| 4 | Product Packaging Issue | 21 | 23.0 | 23.2 | signal |
| 5 | Renal Injury | 67 | 22.7 | 23.4 | signal |
| 6 | Tubulointerstitial Nephritis | 37 | 20.1 | 20.4 | signal |
| 7 | Poor Quality Product Administered | 20 | 19.9 | 20.1 | signal |
| 8 | Therapeutic Response Unexpected | 88 | 19.9 | 20.7 | signal |
| 9 | Product Taste Abnormal | 24 | 18.1 | 18.3 | signal |
| 10 | Nephropathy | 16 | 17.3 | 17.4 | signal |
| 11 | Acute Kidney Injury | 238 | 15.9 | 17.8 | signal |
| 12 | Gastrooesophageal Reflux Disease | 121 | 15.3 | 16.2 | signal |
| 13 | Accidental Overdose | 48 | 13.3 | 13.6 | signal |
| 14 | Renal Failure | 151 | 11.5 | 12.3 | signal |
| 15 | Dysgeusia | 67 | 9.1 | 9.4 | signal |
| 16 | Exposure During Pregnancy | 53 | 8.6 | 8.8 | signal |
| 17 | Product Odour Abnormal | 8 | 7.8 | 7.8 | signal |
| 18 | Incorrect Drug Administration Duration | 21 | 7.5 | 7.5 | signal |
| 19 | Drug Effect Incomplete | 26 | 7.2 | 7.2 | signal |
| 20 | Incorrect Product Administration Duration | 13 | 6.5 | 6.5 | signal |
| 21 | Dyspepsia | 60 | 6.2 | 6.4 | signal |
| 22 | Renal Tubular Necrosis | 6 | 6.2 | 6.2 | signal |
| 23 | Expired Product Administered | 20 | 6.1 | 6.2 | signal |
| 24 | Contraindicated Product Administered | 17 | 5.7 | 5.8 | signal |
| 25 | Retching | 11 | 5.2 | 5.3 | signal |
| 26 | Oral Discomfort | 7 | 5.1 | 5.1 | signal |
| 27 | Laceration | 4 | 4.3 | 4.3 | signal |
| 28 | Wrong Technique In Product Usage Process | 81 | 4.1 | 4.2 | signal |
| 29 | Incorrect Dose Administered | 85 | 3.8 | 4.0 | signal |
| 30 | Accidental Exposure To Product | 37 | 3.8 | 3.8 | signal |
| 31 | Psychomotor Hyperactivity | 6 | 3.7 | 3.7 | signal |
| 32 | Glossodynia | 7 | 3.2 | 3.2 | signal |
| 33 | Overdose | 56 | 2.6 | 2.7 | signal |
| 34 | Drug Dispensing Error | 4 | 2.6 | 2.6 | no signal |
| 35 | Extra Dose Administered | 9 | 2.3 | 2.3 | signal |
| 36 | Drug Prescribing Error | 4 | 2.1 | 2.1 | no signal |
| 37 | Gastric Cancer | 5 | 2.0 | 2.0 | no signal |
| 38 | Drug Effect Decreased | 9 | 1.7 | 1.7 | no signal |
| 39 | Product Complaint | 3 | 1.2 | 1.2 | no signal |